Add and Hyperacusis
Summary:
Hyperacusis is found among people with Add, especially for people who are male, 10-19 old.
The study analyzes which people have Hyperacusis with Add. It is created by eHealthMe based on reports of 94 people who have Add from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Add?
Add (attention deficit disorder-difficult to define) is found to be associated with 806 drugs and 1,366 conditions by eHealthMe. Check the latest studies of Add.
What is Hyperacusis?
Hyperacusis (disorder in loudness perception) is found to be associated with 464 drugs and 600 conditions by eHealthMe. Check the latest studies of Hyperacusis.
94 people who have Add and Hyperacusis are studied.

Gender of people who have Add and experienced Hyperacusis *:
- female: 41.76 %
- male: 58.24 %
Age of people who have Add and experienced Hyperacusis *:
- 0-1: 0.0 %
- 2-9: 24.69 %
- 10-19: 25.93 %
- 20-29: 7.41 %
- 30-39: 17.28 %
- 40-49: 11.11 %
- 50-59: 11.11 %
- 60+: 2.47 %
Common co-existing conditions for these people *:
- Depression: 5 people, 5.32%
- Stress And Anxiety: 2 people, 2.13%
- Quit Smoking: 2 people, 2.13%
- Bipolar Disorder (mood disorder): 2 people, 2.13%
- Oppositional Defiant Disorder (a childhood disorder described by the diagnostic and statistical manual of mental disorders): 2 people, 2.13%
- Neuralgia (pain in one or more nerves): 2 people, 2.13%
- Breast Cancer: 2 people, 2.13%
- Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 1.06%
- Anger: 1 person, 1.06%
- Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 1 person, 1.06%
Common drugs taken by these people *:
- Strattera: 19 people, 20.21%
- Vyvanse: 15 people, 15.96%
- Concerta: 15 people, 15.96%
- Ritalin: 10 people, 10.64%
- Daytrana: 6 people, 6.38%
- Lisdexamfetamine Dimesylate: 5 people, 5.32%
- Abilify: 4 people, 4.26%
- Vitamin C: 4 people, 4.26%
- Qelbree: 4 people, 4.26%
- Vitamin D: 4 people, 4.26%
Common symptoms for these people *:
- Stress And Anxiety: 22 people, 23.40%
- Headache (pain in head): 21 people, 22.34%
- Disturbance In Attention: 15 people, 15.96%
- Fatigue (feeling of tiredness): 15 people, 15.96%
- Feeling Abnormal: 15 people, 15.96%
- Nausea (feeling of having an urge to vomit): 14 people, 14.89%
- Photophobia (extreme sensitivity to light): 14 people, 14.89%
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 13 people, 13.83%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 12 people, 12.77%
- Depression: 11 people, 11.70%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Hyperacusis?
Check whether Hyperacusis is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Add (120,228 reports)
- Hyperacusis (4,388 reports)
All the drugs that are associated with Hyperacusis:
- Hyperacusis (464 drugs)
All the conditions that are associated with Hyperacusis:
- Hyperacusis (600 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Hyperacusis and Add, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lovastatin and Magnevist - 8 seconds ago
- Could Buspirone Hydrochloride cause Constipation? - 20 seconds ago
- Could Famotidine cause Lung Cancer - Non-Small Cell? - 20 seconds ago
- Muscle Spasms and Compression Fracture - 24 seconds ago
- Drug interactions of Flecainide Acetate and Takhzyro - 31 seconds ago
- Drug interactions of Pantoprazole Sodium and Levitra - 37 seconds ago
- Could Adrucil cause Thrombocytopenia? - 45 seconds ago
- Could Braftovi cause Skin Blushing/Flushing? - 47 seconds ago
- Could Braftovi cause Skin Cancer? - 54 seconds ago
- Vaginal Bleeding Between Periods in Folic Acid, how severe and when it was recovered? - a minute ago